
Integrated Research Ltd
ASX:IRI

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.3
0.96
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
IRI
stock under the Base Case scenario is
0.889
AUD.
Compared to the current market price of 0.425 AUD,
Integrated Research Ltd
is
Undervalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Integrated Research Ltd
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.

Valuation History
Historical valuation for IRI cannot be conducted due to limitations such as insufficient data or other constraints.
Fundamental Analysis

Select up to 3 indicators:
Select up to 3 indicators:


Revenue & Expenses Breakdown
Integrated Research Ltd
Balance Sheet Decomposition
Integrated Research Ltd
Current Assets | 77.9m |
Cash & Short-Term Investments | 33m |
Receivables | 41.9m |
Other Current Assets | 3m |
Non-Current Assets | 36.3m |
Long-Term Investments | 319k |
PP&E | 285k |
Other Non-Current Assets | 35.7m |
Current Liabilities | 24.9m |
Accounts Payable | 6.1m |
Accrued Liabilities | 3.3m |
Other Current Liabilities | 15.5m |
Non-Current Liabilities | 887k |
Long-Term Debt | 374k |
Other Non-Current Liabilities | 513k |
Free Cash Flow Analysis
Integrated Research Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Integrated Research Ltd
Revenue
|
83.3m
AUD
|
Operating Expenses
|
-57.9m
AUD
|
Operating Income
|
25.4m
AUD
|
Other Expenses
|
1.7m
AUD
|
Net Income
|
27.1m
AUD
|
IRI Profitability Score
Profitability Due Diligence
Integrated Research Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Score
Integrated Research Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
IRI Solvency Score
Solvency Due Diligence
Integrated Research Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Score
Integrated Research Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IRI Price Targets Summary
Integrated Research Ltd
According to Wall Street analysts, the average 1-year price target for
IRI
is 0.765 AUD
with a low forecast of 0.758 AUD and a high forecast of 0.788 AUD.
Dividends
Current shareholder yield for IRI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IRI
stock under the Base Case scenario is
0.889
AUD.
Compared to the current market price of 0.425 AUD,
Integrated Research Ltd
is
Undervalued by 52%.